“…Cannabinoids were shown to inhibit gastrointestinal motility (Izzo et al, 1999;Krowicki et al, 1999), gastric acid secretion (Adami et al, 2002) and development of gastric mucosal lesions both in acid-dependent (Germano et al, 2001;Rutkowska and Fereniec-Goltbiewska, 2006) and acid-independent ulcer models (Shujaa et al, 2009). Accordingly, CB 1 receptors were identified in neurons of the enteric nervous system and in sensory terminals of vagal and spinal neurons, moreover, CB 1 receptors are also identified in the dorsal vagal complex: in the nucleus of the solitary tract (NTS) (Partosoedarso et al, 2003), in the dorsal motor nucleus of vagus (DMNV) (Mackie, 2005) and prominently, in the area postrema (Mackie, 2005).…”